322 related articles for article (PubMed ID: 34120224)
21. A comparative analysis of axillary nodal burden in ultrasound/biopsy positive axilla vs ultrasound negative sentinel lymph node biopsy positive axilla.
Tandon M; Ball W; Kirby R; Soumian S; Narayanan S
Breast Dis; 2019; 38(3-4):93-96. PubMed ID: 30909179
[TBL] [Abstract][Full Text] [Related]
22. A Model Incorporating Axillary Tail Position on Mammography for Preoperative Prediction of Non-sentinel Lymph Node Metastasis in Patients with Initial cN+ Breast Cancer after Neoadjuvant Chemotherapy.
Zhu T; Lin X; Zhang T; Li W; Gao H; Yang C; Ji F; Zhang Y; Zhang J; Pan W; Zhuang X; Shen B; Chen Y; Wang K
Acad Radiol; 2022 Dec; 29(12):e271-e278. PubMed ID: 35504810
[TBL] [Abstract][Full Text] [Related]
23. An MRI-based Scoring System for Preoperative Prediction of Axillary Response to Neoadjuvant Chemotherapy in Node-Positive Breast Cancer: A Multicenter Retrospective Study.
Huang X; Shi Z; Mai J; Liu C; Liu C; Chen S; Lu H; Li Y; He B; Li J; Cun H; Han C; Chen X; Liang C; Liu Z
Acad Radiol; 2023 Jul; 30(7):1257-1269. PubMed ID: 36280517
[TBL] [Abstract][Full Text] [Related]
24. Sentinel lymph node biopsy after neoadjuvant chemotherapy predicts pathological axillary lymph node status in breast cancer patients with clinically positive axillary lymph nodes at presentation.
Takei H; Yoshida T; Kurosumi M; Inoue K; Matsumoto H; Hayashi Y; Higuchi T; Uchida S; Ninomiya J; Kubo K; Oba H; Nagai S; Tabei T
Int J Clin Oncol; 2013 Jun; 18(3):547-53. PubMed ID: 22588780
[TBL] [Abstract][Full Text] [Related]
25. Imaging response and residual metastatic axillary lymph node disease after neoadjuvant chemotherapy for primary breast cancer.
Hieken TJ; Boughey JC; Jones KN; Shah SS; Glazebrook KN
Ann Surg Oncol; 2013 Oct; 20(10):3199-204. PubMed ID: 23846781
[TBL] [Abstract][Full Text] [Related]
26. Axillary ultrasound for prediction of response to neoadjuvant therapy in the context of surgical strategies to axillary dissection in primary breast cancer: a systematic review of the current literature.
Banys-Paluchowski M; Gruber IV; Hartkopf A; Paluchowski P; Krawczyk N; Marx M; Brucker S; Hahn M
Arch Gynecol Obstet; 2020 Feb; 301(2):341-353. PubMed ID: 31897672
[TBL] [Abstract][Full Text] [Related]
27. Accuracy of axillary ultrasound after different neoadjuvant chemotherapy cycles in breast cancer patients.
Ye BB; Zhao HM; Yu Y; Ge J; Wang X; Cao XC
Oncotarget; 2017 May; 8(22):36696-36706. PubMed ID: 27852041
[TBL] [Abstract][Full Text] [Related]
28. Axillary sentinel lymph node biopsy after neoadjuvant chemotherapy for carcinoma of the breast.
Schwartz GF; Tannebaum JE; Jernigan AM; Palazzo JP
Cancer; 2010 Mar; 116(5):1243-51. PubMed ID: 20087958
[TBL] [Abstract][Full Text] [Related]
29. Initial results of a novel technique of clipped node localization in breast cancer patients postneoadjuvant chemotherapy: Skin Mark clipped Axillary nodes Removal Technique (SMART trial).
Lim GH; Teo SY; Gudi M; Ng RP; Pang J; Tan YS; Lee YS; Allen JC; Leong LCH
Cancer Med; 2020 Mar; 9(6):1978-1985. PubMed ID: 31970894
[TBL] [Abstract][Full Text] [Related]
30. Validation of the targeted axillary dissection technique in the axillary staging of breast cancer after neoadjuvant therapy: Preliminary results.
Flores-Funes D; Aguilar-Jiménez J; Martínez-Gálvez M; Ibáñez-Ibáñez MJ; Carrasco-González L; Gil-Izquierdo JI; Chaves-Benito MA; Ayala-De La Peña F; Nieto-Olivares A; Aguayo-Albasini JL
Surg Oncol; 2019 Sep; 30():52-57. PubMed ID: 31500785
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic Accuracy of Axillary Ultrasound for Prediction of Axillary Pathologic Response after Neoadjuvant Treatment in Breast Cancer.
Tasdoven I; Erdemir RU; Cakmak GK
Chirurgia (Bucur); 2021; 116(2 Suppl):45-58. PubMed ID: 33963694
[No Abstract] [Full Text] [Related]
32. A model to predict pathologic complete response of axillary lymph nodes to neoadjuvant chemo(immuno)therapy in patients with clinically node-positive breast cancer.
Schipper RJ; Moossdorff M; Nelemans PJ; Nieuwenhuijzen GA; de Vries B; Strobbe LJ; Roumen RM; van den Berkmortel F; Tjan-Heijnen VC; Beets-Tan RG; Lobbes MB; Smidt ML
Clin Breast Cancer; 2014 Oct; 14(5):315-22. PubMed ID: 24548732
[TBL] [Abstract][Full Text] [Related]
33. The clinical utility of assessment of the axilla in women with suspicious screen detected breast lesions in the post Z0011 era.
Farshid G; Kollias J; Grantley Gill P
Breast Cancer Res Treat; 2015 Jun; 151(2):347-55. PubMed ID: 25904216
[TBL] [Abstract][Full Text] [Related]
34. Impact of axillary ultrasound (AUS) on axillary dissection in breast conserving surgery (BCS).
Reyna C; Kiluk JV; Frelick A; Khakpour N; Laronga C; Lee MC
J Surg Oncol; 2015 Jun; 111(7):813-8. PubMed ID: 25753101
[TBL] [Abstract][Full Text] [Related]
35. Assessment of axillary node status by ultrasound after neoadjuvant chemotherapy in patients with clinically node-positive breast cancer according to breast cancer subtype.
Maeshima Y; Sakai T; Ogiya A; Takahashi Y; Miyagi Y; Kokubu Y; Osako T; Ito Y; Takahashi S; Ohno S; Ueno T
Sci Rep; 2021 May; 11(1):10858. PubMed ID: 34035335
[TBL] [Abstract][Full Text] [Related]
36. Axillary Ultrasound Accurately Excludes Clinically Significant Lymph Node Disease in Patients With Early Stage Breast Cancer.
Tucker NS; Cyr AE; Ademuyiwa FO; Tabchy A; George K; Sharma PK; Jin LX; Sanati S; Aft R; Gao F; Margenthaler JA; Gillanders WE
Ann Surg; 2016 Dec; 264(6):1098-1102. PubMed ID: 26779976
[TBL] [Abstract][Full Text] [Related]
37. Targeted Axillary Dissection with
Munck F; Andersen IS; Vejborg I; Gerlach MK; Lanng C; Kroman NT; Tvedskov THF
Ann Surg Oncol; 2023 Jul; 30(7):4135-4142. PubMed ID: 37062781
[TBL] [Abstract][Full Text] [Related]
38. The Comparative Study of Ultrasonography, Contrast-Enhanced MRI, and (18)F-FDG PET/CT for Detecting Axillary Lymph Node Metastasis in T1 Breast Cancer.
Hwang SO; Lee SW; Kim HJ; Kim WW; Park HY; Jung JH
J Breast Cancer; 2013 Sep; 16(3):315-21. PubMed ID: 24155761
[TBL] [Abstract][Full Text] [Related]
39. Added Value of MRI for Invasive Breast Cancer including the Entire Axilla for Evaluation of High-Level or Advanced Axillary Lymph Node Metastasis in the Post-ACOSOG Z0011 Trial Era.
Byon JH; Park YV; Yoon JH; Moon HJ; Kim EK; Kim MJ; You JK
Radiology; 2021 Jul; 300(1):46-54. PubMed ID: 33904772
[TBL] [Abstract][Full Text] [Related]
40. Axillary Lymph Node Ultrasound Following Neoadjuvant Chemotherapy in Biopsy-Proven Node-Positive Breast Cancer: Results from the SN FNAC Study.
Morency D; Dumitra S; Parvez E; Martel K; Basik M; Robidoux A; Poirier B; Holloway CMB; Gaboury L; Sideris L; Meterissian S; Boileau JF
Ann Surg Oncol; 2019 Dec; 26(13):4337-4345. PubMed ID: 31605348
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
